| Particulars |
|
|
|
| Company Name
| Neuland Laboratories Ltd
| Year End
| 202603
|
| Full Year |
| Equity (₹ Cr.) |
12.83 |
B.V. (₹) |
1,453.60 |
| Sales(₹ Cr.) |
2,022.99 |
NP (₹ Cr.) |
360.22 |
| NP Var% |
108.00 |
Div% |
340.00 |
| CPS(₹) |
352.30 |
EPS (₹) |
280.80 |
| Traded Value(₹ Lakhs) |
2,856.38 |
52 Week High |
23,451.00 |
| 52 Week Low |
11,500.00 |
Price BSE |
22,844.00 |
| Price NSE |
22,855.00 |
Market Capital (₹ Cr.) |
29,308.02 |
| P/C Ratio |
64.80 |
P/E Ratio |
81.40 |
| Price Vs.BV |
15.72 |
|
| Latest Quarter |
| Year End |
202606 |
Sales (₹ Cr.) |
641.58 |
| NP(₹ Cr.) |
147.36 |
NP Var % |
975.00 |
| Trailing Twelve Months |
| Year End |
202606 |
Sales |
1,528.28 |
| OPM |
26.99 |
NP |
263.04 |
| NP Var% |
280.80 |
EPS |
387.19 |
| PE |
59.00 |
|
|